We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GWH:NYSEESS Tech, Inc. Analysis

Data as of 2026-09-29 - not real-time

$0.19

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind ESS Tech, Inc. is bearish at $0.1868, with short-term averages lagging the long-term ones. Over a rolling month the price has lost 69.3%. Relative strength is 25.7 — oversold — and the MACD signal is bearish. Recent trading has carved out support near $0.1690 and resistance around $0.4330.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 970.7% above today's level. Revenue is contracting at 96.9%.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 227.9%, a beta of 1.01 and a maximum drawdown of 98.0%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.

Top Market Events

ESS Tech GWH delivered earnings and revenue surprises of -4.NEW YORK, July 01, 2026--The New York Stock Exchange "NYSE", the "Exchange" announced today that the staff of NYSE...NEW YORK, September 24, 2026--The New York Stock Exchange "NYSE", the "Exchange" announced today that the staff of NYSE...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 25.7 signals oversold conditions
  • Trading below the 200-day average of 1.10

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • RSI at 25.7 signals oversold conditions
  • Trading below the 200-day average of 1.10

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Analyst targets imply +970.7% versus the current price
  • Negative return on equity of -21339.7%
  • Revenue contracting at -96.9%

Key Metrics & Analysis

Financial Health

Revenue Growth-96.90%
P/E Ratio-0.2
ROE-21339.71%
ROA-87.77%
P/B Ratio0.5
Op. Cash Flow$-42089000
Free Cash Flow$-33593876
Industry P/E27.5

Technical Analysis

TrendBearish
RSI25.7
Support$0.17
Resistance$0.43
MA 20$0.33
MA 50$0.50
MA 200$1.10
MACDBearish
VolumeIncreasing
Fear & Greed Index93.04

Valuation

Target Price$2.00
Upside/Downside970.66%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.01
Volatility227.92%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.